Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 36
Filter
Add more filters











Publication year range
1.
Brain Pathol ; 26(1): 43-61, 2016 Jan.
Article in English | MEDLINE | ID: mdl-25808628

ABSTRACT

Although BMP4-induced differentiation of glioma stem cells (GSCs) is well recognized, details of the cellular responses triggered by this morphogen are still poorly defined. In this study, we established several GSC-enriched cell lines (GSC-ECLs) from high-grade gliomas. The expansion of these cells as adherent monolayers, and not as floating neurospheres, enabled a thorough study of the phenotypic changes that occurred during their differentiation. Herein, we evaluated GSC-ECLs' behavior toward differentiating conditions by depriving them of growth factors and/or by adding BMP4 at different concentrations. After analyzing cellular morphology, proliferation and lineage marker expression, we determined that GSC-ECLs have distinct preferences in lineage choice, where some of them showed an astrocyte fate commitment and others a neuronal one. We found that this election seems to be dictated by the expression pattern of BMP signaling components present in each GSC-ECL. Additionally, treatment of GSC-ECLs with the BMP antagonist, Noggin, also led to evident phenotypic changes. Interestingly, under certain conditions, some GSC-ECLs adopted an unexpected smooth muscle-like phenotype. As a whole, our findings illustrate the wide differentiation potential of GSCs, highlighting their molecular complexity and paving a way to facilitate personalized differentiating therapies.


Subject(s)
Bone Morphogenetic Protein 4/metabolism , Brain Neoplasms/pathology , Carrier Proteins/metabolism , Glioma/pathology , Neoplastic Stem Cells/metabolism , Neoplastic Stem Cells/pathology , Aged , Antigens, CD/metabolism , Bone Morphogenetic Protein 4/pharmacology , Carrier Proteins/pharmacology , Cell Differentiation/drug effects , Cell Differentiation/genetics , Female , Gene Expression Regulation, Neoplastic/genetics , Humans , Intercellular Signaling Peptides and Proteins/pharmacology , Male , Middle Aged , Nerve Tissue Proteins/metabolism , Phenotype , Signal Transduction/drug effects , Signal Transduction/physiology , Tumor Cells, Cultured/pathology , Tumor Cells, Cultured/physiology
2.
Hist. ciênc. saúde-Manguinhos ; Hist. ciênc. saúde-Manguinhos;21(4): 1397-1415, Oct-Dec/2014.
Article in Spanish | LILACS | ID: lil-732516

ABSTRACT

Se analiza el significado del concepto de “obsesión” en el alienismo del siglo XIX. Desde el punto de vista clínico, la descripción de Esquirol fue completada por otros autores (Jules Falret, Legrand du Saulle). En el ámbito de la reflexión psicopatológica, el alienismo francés, con el delirio emotivo de Morel o la psicastenia de Janet, defendió la teoría emocional, frente al trastorno intelectual propuesto por los médicos alemanes. Finalmente, se insiste en la importancia del marco cultural en la aparición de los síntomas obsesivos y de su interpretación. En este sentido, se estudian las relaciones de los escrúpulos religiosos con la melancolía o la aparición de categorías diagnósticas sometidas a los códigos y mentalidades fin-de-siècle.


The article analyses the significance of the concept of “obsession” in nineteenth-century alienism. From a clinical point of view, Esquirol’s description was completed by other authors (Jules Falret, Legrand du Saulle). In the area of psychopathological studies, French alienism, with Morel’s emotional delirium or Janet’s psychasthenia, defended the emotional theory, as opposed to the intellectual disorder proposed by German doctors. Lastly, the importance of the cultural framework is stressed in the appearance of obsessive symptoms and their interpretation. Along these lines, the article discusses the relationship of religious scruples to melancholy or the appearance of diagnostic categories subject to fin de siècle codes and mentalities.


Subject(s)
Humans , Antineoplastic Agents/pharmacology , DNA, Complementary/genetics , Floxuridine/pharmacology , Platelet-Derived Growth Factor/genetics , Thymidine Phosphorylase/genetics , Cell Communication , Drug Screening Assays, Antitumor , Transfection , Tumor Cells, Cultured/drug effects , Tumor Cells, Cultured/enzymology , Tumor Cells, Cultured/pathology
3.
Braz. dent. j ; Braz. dent. j;25(5): 435-441, Sep-Oct/2014. tab, graf
Article in English | LILACS | ID: lil-731060

ABSTRACT

This study compared the physicochemical properties and interfacial adaptation to canal walls of Endo-CPM-Sealer, Sealapex and Activ GP with the well-established AH Plus sealer. The following analyses were performed: radiopacity, pH variation and solubility using samples of each material and scanning electron microscopy of root-filled bovine incisors to evaluate the interfacial adaptation. Data were analyzed by the parametric and no-parametric tests (α=0.05). All materials were in accordance with the ANSI/ADA requirements for radiopacity. Endo-CPM-Sealer presented the lowest radiopacity values and AH Plus was the most radiopaque sealer (p=0.0001). Except for ActiV GP, which was acidic, all other sealers had basic chemical nature and released hydroxyl ions. Regarding solubility, all materials met the ANSI/ADA recommendations, with no statistically significant difference between the sealers (p=0.0834). AH Plus presented the best adaptation to canal walls in the middle (p=0.0023) and apical (p=0.0012) thirds, while the sealers Activ GP and Endo-CPM-Sealer had poor adaptation to the canal walls. All sealers, except for ActiV GP, were alkaline and all of them fulfilled the ANSI/ADA requirements for radiopacity and solubility. Regarding the interfacial adaptation, AH Plus was superior to the others considering the adaptation to the bovine root canal walls.


Este estudo comparou as propriedades físico-químicas e a adaptação interfacial às paredes do canal dos cimentos Endo-CPM-Sealer, Sealapex e Activ GP com o bem estabelecido cimento AH Plus. As seguintes análises foram realizadas: radiopacidade, variação de pH e de solubilidade utilizando amostras de cada material, e microscopia eletrônica de varredura utilizando incisivos bovinos obturados para avaliar a adaptação interfacial. Os dados foram analisados utilizando testes paramétricos e não-paramétricos (α=0,05). Todos os materiais estavam de acordo com os requerimentos da ANSI/ADA para radiopacidade, sendo que o Endo-CPM-Sealer apresentou os menores valores de radiopacidade e o AH Plus foi o cimento mais radiopaco (p=0,0001). Exceto o Activ GP, que foi ácido, todos os outros cimentos apresentaram natureza química básica e liberaram íons hidroxila. Com relação à solubilidade, todos os materiais estavam de acordo com as recomendações da ANSI /ADA, sem diferença significante entre os cimentos (p=0,0834). O AH Plus apresentou a melhor adaptação às paredes do canal nos terços médio (p=0,0023) e apical (p=0,0012), enquanto que os cimentos Activ GP e Endo-CPM-Sealer apresentaram uma pobre adaptação às paredes do canal. Em conclusão, todos os cimentos, exceto o Activ GP, foram alcalinos e todos preencheram os requerimentos da ANSI/ADA para radiopacidade e solubilidade. Com relação à adaptação interfacial, o AH Plus foi superior aos demais para adaptação às paredes do canal radicular de incisivos bovinos.


Subject(s)
Animals , Female , Humans , Mice , Angiogenesis Inhibitors/pharmacology , Antineoplastic Agents/pharmacology , Breast Neoplasms/drug therapy , Breast Neoplasms/pathology , Dextrans/pharmacology , Growth Inhibitors/pharmacology , Tumor Cells, Cultured/drug effects , Tumor Cells, Cultured/pathology , Angiogenesis Inhibitors/therapeutic use , Antineoplastic Agents/therapeutic use , Culture Media, Conditioned/pharmacology , Dose-Response Relationship, Drug , Dextrans/chemistry , Dextrans/therapeutic use , Endothelium, Vascular/cytology , Endothelium, Vascular/drug effects , Endothelium, Vascular/physiology , Growth Inhibitors/therapeutic use , Mice, Inbred BALB C , Mice, Nude , Necrosis , Phenylacetates/pharmacology , Phenylacetates/therapeutic use , Xenograft Model Antitumor Assays/statistics & numerical data
4.
Cell Biochem Biophys ; 42(1): 61-74, 2005.
Article in English | MEDLINE | ID: mdl-15673929

ABSTRACT

Treatment with direct electric current (DC) influences the growth of several cancer cells. In this work, we evaluated the effects of DC treatment on the human leukemic cell line HL60. Human cells were separately treated in the presence of the cathode or the anode or without contact with the electrodes. In all systems, DC-treated cells presented an impaired ability to proliferate. Growth inhibition was dependent on the generation of soluble products of electrolysis. Cathodic treatment of HL60 cells predominantly induced lysis, whereas treatment without contact with electrodes did not induce alterations in cell viability. In contrast, cell stimulation by the anode resulted in irreversible membrane damage, as demonstrated by trypan blue and 7-aminoactinomycin staining. Analysis of these cells by transmission electron microscopy indicated that necrosis is a major mechanism inducing cell death. In addition, apoptotic-like cells were observed under light microscopy after anodic treatment. Accordingly, DNA from anodic-treated cells presented a typical pattern of apoptosis. Apoptotic cell death was only generated after the treatment of HL60 cells in conditions in which the generation of chloride-derived compounds was favored. These results indicate that the nature of the products from cathodic or anodic reactions differently influences the mechanisms of cell death induced by DC-derived toxic compounds.


Subject(s)
Cell Death/radiation effects , Electric Stimulation , Electricity , Tumor Cells, Cultured/radiation effects , Cell Membrane/metabolism , Cell Membrane/radiation effects , HL-60 Cells , Humans , Leukemia/pathology , Necrosis , Time Factors , Tumor Cells, Cultured/pathology
5.
Braz J Med Biol Res ; 36(12): 1761-8, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14666262

ABSTRACT

The objective of the present study was to determine the effects of retinoic acid on the growth of the mouse mammary cells HC11 and HC11ras, which are a model for in vitro breast cancer progression. The expression of the two classes (RARs and RXRs) of retinoic acid receptor mRNAs was determined by Northern blot analysis. Receptor functional integrity was determined by testing whether RAR mRNA could be induced by retinoic acid. The effects of a 72-h exposure to 50 M 13-cis retinoic acid on HC11 and HC11ras cell proliferation and HC11 cell differentiation were investigated by flow cytometric cell cycle analysis, and by determination of -casein mRNA expression, respectively. The possibility that retinoic acid would induce the expression of the vitamin D receptor and synergize with vitamin D, a known inhibitor of HC11 cell growth, was also investigated. HC11 cells expressed higher mRNA levels of both RAR a and RAR g when compared to HC11ras cells. In contrast, RAR , as well as RXR a, and g expression was low in both HC11 and HC11ras cells. In addition, RAR mRNA was induced by retinoic acid treatment in both cells. In spite of these observations, no effects were seen on cell proliferation or differentiation upon exposure to retinoic acid. Neither vitamin D receptor induction nor synergy with vitamin D on growth inhibition was observed. We conclude that the RAR expression profile could be related to the transformed state in HC11ras cells and that the retinoic acid resistance observed merits further investigation.


Subject(s)
Cell Transformation, Neoplastic/drug effects , Mammary Glands, Animal/drug effects , Tretinoin/pharmacology , Animals , Blotting, Northern , Cell Division/drug effects , Cell Transformation, Neoplastic/pathology , Female , Gene Expression Regulation , Genes, ras/drug effects , Mammary Glands, Animal/pathology , Mice , RNA, Messenger/analysis , Receptors, Retinoic Acid/analysis , Tumor Cells, Cultured/drug effects , Tumor Cells, Cultured/pathology , Vitamin D/pharmacology
6.
Hematology ; 8(3): 155-63, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12745649

ABSTRACT

Chronic myeloid leukemia (CML) is a hematological neoplasia that results from the transformation of a hematopoietic stem cell. It is characterized by the expansion of the myeloid lineage, which results in the accumulation of mature and immature granulocytes in peripheral blood and bone marrow. However, when CML marrow cells are cultured in Dexter-type long-term cultures (LTMC) hematopoiesis is defective and can be sustained for only a few weeks. One possible explanation for the deficient growth of hematopoietic cells in CML LTMC is that some factors that act as key regulators of hematopoiesis are absent in this experimental system. Thus, we tested this hypothesis by adding recombinant cytokines to these cultures. As a first approach, we added recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF), rhGranulocyte-CSF (rhG-CSF) and rhErythropoietin (rhEPO); each factor was added individually once a week. Addition of rhGM-CSF and rhG-CSF resulted in a significant increase in the levels of nucleated cells and myeloid progenitors; the highest effects were seen in the presence of rhGM-CSF. Interestingly, such a cytokine also induced a significant decrease in the levels of erythroid progenitors. Recombinant hEPO had no significant effects on nucleated cells or myeloid progenitors, however, it induced a significant, although transient, increase in the levels of erythroid cells. The above results indicate that the hematopoietic regulators used here (rhGM-CSF, rhG-CSF and rhEPO) are capable of stimulating the growth of hematopoietic cells in LTMC from CML patients. Thus, this study demonstrates that it is, indeed, possible to manipulate CML LTMC by the addition of recombinant cytokines; this observation may be of particular relevance, since this in vitro experimental system has already been used as a method for purging of leukemic cells in autologous transplant settings. By using specific recombinant hematopoietic modulators it might be possible to make LTMC a more efficient system for such a clinical purpose.


Subject(s)
Hematopoiesis/drug effects , Hematopoietic Stem Cells/drug effects , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/pathology , Neoplastic Stem Cells/drug effects , Tumor Cells, Cultured/drug effects , Adult , Aged , Aged, 80 and over , Bone Marrow Purging , Cell Lineage , Erythropoietin/pharmacology , Female , Granulocyte Colony-Stimulating Factor/pharmacology , Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology , Hematopoietic Stem Cells/pathology , Humans , Kinetics , Male , Middle Aged , Neoplastic Stem Cells/pathology , Recombinant Proteins/pharmacology , Tumor Cells, Cultured/pathology , Tumor Stem Cell Assay
7.
Oral Oncol ; 39(5): 453-8, 2003 Jul.
Article in English | MEDLINE | ID: mdl-12747969

ABSTRACT

Epithelial-myoepithelial carcinoma of the salivary gland is a rare, low-grade, neoplasm, composed of ductal and myoepithelial cells. We present two novel cell lines, which have been characterised by immunofluorescence, derived from an epithelial-myoepithelial carcinoma of the parotid gland. A resected mass of the parotid gland was diagnosed as an epithelial-myoepithelial carcinoma by routine histological examination. Part of the specimen was labelled with a panel of antibodies confirming the tumour type. The other part was finely minced and the explants were incubated in DMEM supplemented with penicillin and streptomycin, at 37 degrees C in a humidified 5% CO(2) atmosphere. Two cell types were identified by immunofluorescence-a small cobblestone cell, positive for AE1/AE3 and p53, and a polyhedral cell, positive for vimentin, smooth muscle markers and S-100. Herein two cell lines are presented in order to open up possibilities of new studies and a discussion of the events that culminate in this bimodal neoplasm is also performed.


Subject(s)
Carcinoma/pathology , Nuclear Proteins , Parotid Neoplasms/pathology , Tumor Cells, Cultured/pathology , Adult , Carcinoma/chemistry , Cell Culture Techniques/methods , Female , Humans , Keratins/analysis , Neoplasm Proteins/analysis , Parotid Neoplasms/chemistry , Proto-Oncogene Proteins/analysis , Proto-Oncogene Proteins c-mdm2 , Tumor Cells, Cultured/chemistry , Tumor Suppressor Protein p53/analysis
8.
Leuk Res ; 27(5): 413-23, 2003 May.
Article in English | MEDLINE | ID: mdl-12620293

ABSTRACT

Among the mechanisms that induce multidrug resistance (MDR), one of those most frequent is over-expression of a phosphoglycoprotein (Pgp) encoded in the mouse by the mdr-1 and mdr-3 genes. We have demonstrated that cyclosporin-A (CsA) as well as its analogue PSC 833 were able to revert the MDR phenotype in murine cell lines resistant to vincristine (LBR-V160) or doxorubicin (LBR-D160). The aim of this work was to evaluate the ability of PSC 833 and CsA to modulate mdr-1, mdr-3 and mrp-1 genes as well as to induce apoptosis analyzing the mechanism involved in the above tumor cell lines. By semi-quantitative RT-PCR, we demonstrated that mdr-3 was over-expressed in both resistant lines while mdr-1 was over-expressed only in LBR-V160; in contrast, mrp-1 expression was not evidenced in any of the cell lines. After treatment with 0.1 microg ml(-1) of either PSC 833 or CsA, LBR-V160 showed no changes in mdr-1 but decreased mdr-3 expression, while LBR-D160 failed to display any modification in the expression of these genes. Apoptosis was evidenced by fluorescence microscopy, S minuscule accumulation and agarose gel electrophoresis. Our results demonstrated that CsA (1 microg ml(-1)) was able to induce apoptosis in all cell lines: 18.31% (+/-4.46) for LBR-, 25.96% (+/-5.24) for LBR-V160 and 27.36% (+/-4.12) for LBR-D160, while PSC 833 (1 microg ml(-1)) only induced apoptosis 21.51% (+/-5.73) in LBR-V160 cell line. The expression of Bcl-2 family proteins (Bcl-2, Bax and Bcl-x(L)) was analyzed by flow cytometry showing high expression of the three proteins which was not significantly modified after treatment with either PSC 833 or CsA on the sensitive as well as on the resistant cell lines. Single stranded conformation polymorphisms analysis of p53 (Trp53) gene in the cell lines showed no mutation in exons 5-8 of the tumor suppressor gene. We conclude that depending on the concentration used, PSC 833 and CsA may act either by modulating the mdr-3 gene (0.1 microg ml(-1)) or by direct impact on the cells through induction of apoptosis (1 microg ml(-1)), in the latter case through a mechanism that might act independent of the Bcl-2 family proteins.


Subject(s)
Apoptosis/drug effects , Cyclosporine/pharmacology , Cyclosporins/pharmacology , Drug Resistance, Multiple , Drug Resistance, Neoplasm , Genes, MDR , Leukemia, T-Cell/pathology , ATP Binding Cassette Transporter, Subfamily B/antagonists & inhibitors , ATP Binding Cassette Transporter, Subfamily B/biosynthesis , ATP Binding Cassette Transporter, Subfamily B/genetics , ATP-Binding Cassette Transporters/antagonists & inhibitors , ATP-Binding Cassette Transporters/biosynthesis , ATP-Binding Cassette Transporters/genetics , Animals , Antineoplastic Agents/pharmacology , Cell Cycle , Doxorubicin/pharmacology , Exons/genetics , Gene Expression Regulation, Leukemic , Genes, bcl-2 , Genes, p53 , Leukemia, T-Cell/genetics , Mice , Mice, Inbred BALB C , Neoplasm Proteins/antagonists & inhibitors , Neoplasm Proteins/biosynthesis , Neoplasm Proteins/genetics , Phenotype , Polymorphism, Single-Stranded Conformational , Proto-Oncogene Proteins/biosynthesis , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins c-bcl-2/biosynthesis , Proto-Oncogene Proteins c-bcl-2/genetics , Tumor Cells, Cultured/drug effects , Tumor Cells, Cultured/pathology , Vincristine/pharmacology , bcl-2-Associated X Protein , bcl-X Protein
9.
Biochemistry ; 42(7): 2116-21, 2003 Feb 25.
Article in English | MEDLINE | ID: mdl-12590600

ABSTRACT

Arginine vasopressin (AVP) is a nonapeptide long known as an endocrine and paracrine regulator of important systemic functions, namely, vasoconstriction, gluconeogenesis, corticosteroidogenesis, and excretion of water and urea. Here we report, for the first time, that AVP specifically inhibits expression of the cyclin D1 gene, leading to cell cycle blockage and halting cell proliferation. In G0/G1-arrested mouse Y1 adrenocortical tumor cells, maintained in serum-free medium (SFM), AVP mimics FGF2, promoting rapid ERK1/2 activation (5 min) followed by c-Fos protein induction (2 h). PKC inhibitor Go6983 and PI3K inhibitors wortmannin and LY294002 all inhibit ERK1/2 activation by AVP, but not by FGF2. Thus, AVP and FGF2 concur to activate ERK1/2 by different regulatory pathways. However, AVP is not a mitogenic factor for Y1 cells. On the contrary, AVP strongly antagonizes FGF2 late induction (2-5 h) of the cyclin D1 gene, down-regulating both cyclin D1 mRNA and protein. AVP inhibition of cyclin D1 expression is sufficient to block G1 phase progression and cell entry into the S phase, monitored by BrdU nuclear labeling. In addition, AVP completely inhibits proliferation of Y1 cells in 10% fetal calf serum (10% FCS) medium. On the other hand, ectopic expression of the cyclin D1 protein renders Y1 cells resistant to AVP for both entry into the S phase in SFM and continuous proliferation in 10% FCS medium. In conclusion, inhibition of cyclin D1 expression by AVP is an efficient mechanism of cell cycle blockage and consequent proliferation inhibition in Y1 adrenocortical cells.


Subject(s)
Arginine Vasopressin/physiology , Cell Cycle/physiology , Cyclin D1/antagonists & inhibitors , Cyclin D1/biosynthesis , Gene Expression Regulation/physiology , Growth Inhibitors/physiology , Tumor Cells, Cultured/metabolism , Tumor Cells, Cultured/pathology , Adrenal Cortex Neoplasms/enzymology , Adrenal Cortex Neoplasms/metabolism , Adrenal Cortex Neoplasms/pathology , Animals , Arginine Vasopressin/pharmacology , Cell Cycle/drug effects , Clone Cells , Culture Media, Conditioned , Cyclin D1/genetics , Drug Resistance, Neoplasm , Enzyme Activators/pharmacology , Fibroblast Growth Factor 2/pharmacology , G1 Phase/drug effects , G1 Phase/physiology , Gene Expression Regulation/drug effects , Growth Inhibitors/pharmacology , Mice , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3 , Mitogen-Activated Protein Kinases/metabolism , Molecular Mimicry , Phosphatidylinositol 3-Kinases/physiology , Protein Kinase C/physiology , Resting Phase, Cell Cycle/drug effects , Resting Phase, Cell Cycle/physiology , Transfection , Tumor Cells, Cultured/enzymology
10.
Toxicon ; 40(6): 739-48, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12175610

ABSTRACT

Skmel-28 human melanoma cells were treated with jararhagin (Jara), a metalloproteinase disintegrin isolated from Bothrops jararaca snake venom, and Jari (Jara with the catalytic domain inactivated). Following treatments, monolayer cells lost cytoplasmic expansions acquiring round shapes, detached and formed cell clusters in suspension. Cytotoxicity effect of Jari was dramatically increased at concentrations higher than 0.4 microM, whereas cell adhesion responses did not differ significantly between similar concentrations of Jara and Jari. Treated cells were significantly inhibited to adhere to non-coated wells, as to ECM proteins-coated plates. Migration and invasion were also significantly inhibited in vitro. A decreased proliferation rate was observed in toxin-treated cells. Immunofluorescence staining showed a wide distribution of Jari across the cells. Jara treated cells (67.5%) steady bound anti-jara antibodies after 90 min, while Jari treated cells steady bound only after 6h (57.3%), as determined by FACS. Skmel-28 melanoma cells tumorigenicity was evaluated 180 days after s.c. injections in AIRmin mice. A statistically significant decrease in the ability of Jara and Jari treated cells to promote lung metastasis was observed. These results point to the potential use of this toxin as a tool for applied researches in the clinical field.


Subject(s)
Bothrops , Crotalid Venoms/pharmacology , Metalloendopeptidases/pharmacology , Platelet Aggregation Inhibitors/pharmacology , Tumor Cells, Cultured/drug effects , Animals , Cell Adhesion/drug effects , Cell Movement/drug effects , Cell Survival/drug effects , Crotalid Venoms/metabolism , Dose-Response Relationship, Drug , Fluorescent Antibody Technique, Indirect , Humans , Melanoma/metabolism , Melanoma/secondary , Metalloendopeptidases/metabolism , Neoplasm Transplantation , Platelet Aggregation Inhibitors/metabolism , Skin Neoplasms/metabolism , Skin Neoplasms/pathology , Tumor Cells, Cultured/pathology , Tumor Cells, Cultured/transplantation , Bothrops jararaca Venom
11.
Toxicon ; 40(7): 885-91, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12076641

ABSTRACT

Arenosclerins A-C and haliclonacyclamine E, new tetracyclic alkylpiperidine alkaloids isolated from the marine sponge Arenosclera brasiliensis, were subjected to antimicrobial and cytotoxic bioassays. Fourteen samples of microorganisms were used: Candida albicans, Staphylococcus aureus, Escherichia coli, and 12 antibiotic-resistant bacteria isolated from hospital environment. The minimum inhibitory concentration activity of each alkaloid was determined. The four compounds displayed antibacterial activity, but no antifungal activity against C. albicans. Haliclonacyclamine E and arenosclerins A and C were active against a larger number of bacteria strains than arenosclerin B. However, arenosclerins B and C presented more potent antibacterial activity. The alkaloids displayed inhibitory activity against both Gram positive and Gram negative bacteria. Cytotoxicity bioassays using the MTT method showed that these compounds present cytotoxic activity against human HL-60 (leukemia), L929 (fibrosarcoma), B16 (melanoma) and U138 (colon) cancer cell lines at concentrations between 1.5 and 7.0microg/ml. The results obtained indicated that A. brasiliensis alkaloids have a potent toxic activity. The broad cytotoxic and antimicrobial activities presented by A. brasiliensis alkaloids suggest a defensive role of arenosclerins and haliclonacyclamine E against microbial infection and/or the action of potential predators at the sponge's natural habitat.


Subject(s)
Alkaloids/pharmacology , Anti-Bacterial Agents/pharmacology , Drug Resistance, Bacterial , Macrocyclic Compounds , Piperidines , Porifera , Tumor Cells, Cultured/drug effects , Alkaloids/isolation & purification , Animals , Cell Survival/drug effects , Formazans/metabolism , Gram-Negative Bacteria/drug effects , Gram-Positive Bacteria/drug effects , Microbial Sensitivity Tests , Oligopeptides/isolation & purification , Oligopeptides/pharmacology , Porifera/chemistry , Tetrazolium Salts/metabolism , Tumor Cells, Cultured/metabolism , Tumor Cells, Cultured/pathology
12.
Genet. mol. res. (Online) ; Genet. mol. res. (Online);1(2): 167-175, Jun. 2002.
Article in English | LILACS | ID: lil-417638

ABSTRACT

We developed a model system for testing gene vectors, based on the growth of murine tumors on the chorioallantoic membrane (CAM) of embryonic chickens. The ability of selected murine cells to grow on the CAM was rated according to the following criteria: i) formation of tumor masses; ii) metastasis formation; iii) reproducibility; iv) yield, indicated as the number of embryos surviving to assessment time with visible tumors on the CAM; v) maintainability of the cell, both in the original host and the embryonic chick, or 'shuttle maintainability'; vi) detection by the naked eye, and vii) cost/benefit relation. The murine melanoma cell lineage, B16F10, which efficiently forms distinct, pigmented tumor masses and metastases on the CAM, performed better in this model than the murine B61 cell line. In vitro transduction of B16F10 cells with a recombinant adenovirus carrying a construct of the E. coli LacZ gene followed by inoculation onto the CAM resulted in beta-galactosidase expression in the tumor mass growing on the CAM. This model is potentially applicable to preclinical evaluation of gene vectors, especially for gene therapy of cancer


Subject(s)
Humans , Animals , Adenoviridae/genetics , Genetic Vectors , Melanoma, Experimental/pathology , Allantois , Chick Embryo , Chorion , Cost-Benefit Analysis , Tumor Cells, Cultured/pathology , Mice , Melanoma, Experimental/genetics , Reproducibility of Results
13.
Genet Mol Res ; 1(2): 167-75, 2002 Jun 30.
Article in English | MEDLINE | ID: mdl-14963844

ABSTRACT

We developed a model system for testing gene vectors, based on the growth of murine tumors on the chorioallantoic membrane (CAM) of embryonic chickens. The ability of selected murine cells to grow on the CAM was rated according to the following criteria: i) formation of tumor masses; ii) metastasis formation; iii) reproducibility; iv) yield, indicated as the number of embryos surviving to assessment time with visible tumors on the CAM; v) maintainability of the cell, both in the original host and the embryonic chick, or 'shuttle maintainability'; vi) detection by the naked eye, and vii) cost/benefit relation. The murine melanoma cell lineage, B16F10, which efficiently forms distinct, pigmented tumor masses and metastases on the CAM, performed better in this model than the murine B61 cell line. In vitro transduction of B16F10 cells with a recombinant adenovirus carrying a construct of the E. coli LacZ gene followed by inoculation onto the CAM resulted in beta-galactosidase expression in the tumor mass growing on the CAM. This model is potentially applicable to preclinical evaluation of gene vectors, especially for gene therapy of cancer.


Subject(s)
Adenoviridae/genetics , Genetic Vectors , Melanoma, Experimental/pathology , Allantois , Animals , Chick Embryo , Chorion , Cost-Benefit Analysis , Humans , Melanoma, Experimental/genetics , Mice , Reproducibility of Results , Tumor Cells, Cultured/pathology
14.
Int J Oncol ; 19(6): 1161-7, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11713585

ABSTRACT

Gestational trophoblastic diseases, like the complete hydatidiform mole (CHM), are a group of human interrelated neoplasms whose etiology and progression is poorly understood at the molecular level. We have previously reported the cloning and expression of a new tumor necrosis factor receptor (TNF-R) related transcript, named CHMS-1 that encodes a potential death domain. Here we show that ectopic expression of the putative CHMS-1 death domain specifically induced apoptosis in a dose-dependent manner, in trophoblastic (JEG-3) and non-trophoblastic (COS-7) cells. We also investigated the expression of apoptosis-related molecules such as Bcl-2 and p53 and demonstrated that Bcl-2 is repressed in CHM while p53 is overexpressed in CHM compared with persistent gestational trophoblastic tumors. Altogether, these data indicate that the CHMS-1 death domain is able to trigger apoptosis, thus suggesting that this new entity might be an important inducer of molar regression mechanisms in women.


Subject(s)
Apoptosis , Neoplasm Proteins/metabolism , Receptors, Tumor Necrosis Factor/metabolism , Trophoblasts/metabolism , Animals , Blotting, Northern , Female , Flow Cytometry , Gene Expression , Green Fluorescent Proteins , Humans , Immunoenzyme Techniques , Luminescent Proteins/metabolism , Neoplasm Proteins/genetics , Pregnancy , Proto-Oncogene Proteins c-bcl-2/metabolism , RNA, Messenger/metabolism , Receptors, Tumor Necrosis Factor/genetics , Recombinant Fusion Proteins/metabolism , Transfection , Trophoblasts/pathology , Tumor Cells, Cultured/metabolism , Tumor Cells, Cultured/pathology , Tumor Suppressor Protein p53/metabolism
15.
Int J Oncol ; 18(4): 729-35, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11251167

ABSTRACT

The purpose of this report was the initiation and further maintenance of tumor cells from a primary larynx squamous cell carcinoma. A tumor fragment was mechanically dissociated, the cells were grown in RPMI medium, being the primary culture dependent on the presence of epidermal growth factor and insulin; during subsequent passages the adaptation to conventional growth conditions was obtained. Cells grew in monolayer with an epitheliod shape, showing a pavement-like arrangement; at confluence, cells piled up without contact inhibition maintaining the same morphology. Population doubling time was about 48 h with a colony-forming efficiency of 10%. Immunocytochemical characterization was performed with a panel of monoclonal antibodies reactive against tumor associated antigens, including mucin glycoproteins and related carbohydrate antigens, carcinoembryonic antigen (CEA), p53 as well as cytokeratins, vimentin and desmin. T201 expressed CEA, sialyl Lewis x, Lewis x, Lewis y, MUC1 mucin, Tn hapten, p53, vimentin and cytokeratins. On the other hand, a modal chromosome diploid number of 46 occurring in 74% of cells was detected. Present data confirmed that the methodology employed was adequate for the establishment and characterization of a new cell line which can provide a useful model to study biological and immunological aspects of larynx squamous cell carcinoma.


Subject(s)
Carcinoma, Squamous Cell/pathology , Laryngeal Neoplasms/pathology , Tumor Cells, Cultured/pathology , Animals , Antigens, Neoplasm/analysis , Antigens, Neoplasm/metabolism , Biomarkers, Tumor , Carcinogenicity Tests , Carcinoma, Squamous Cell/metabolism , Cell Division , Cytogenetic Analysis , Electrophoresis, Polyacrylamide Gel , Humans , Immunoenzyme Techniques , Laryngeal Neoplasms/metabolism , Lymphatic Metastasis/pathology , Male , Mice , Mice, Nude , Middle Aged , Neoplasm Proteins/metabolism , Tumor Cells, Cultured/metabolism , Tumor Stem Cell Assay
16.
Cell Mol Neurobiol ; 21(4): 421-8, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11775071

ABSTRACT

1. A human glioma cell line, NG97, was established from tissue obtained from a patient diagnosed with a grade III astrocytoma. 2. The NG97 cell line has been subcultured for more than 100 passages in standard culture media without feeder layer or collagen coatings. 3. NG97 cells grow in vitro as two subpopulations with distinct morphological appearance: stellate cells with pleomorphic nuclei, and small round cells with few processes. The cells have a doubling time of about 72 h and a plating efficiency of 1%. The injection of NG97 cells into congenitally athymic mice induced the formation of solid tumor masses that could be retransplanted every 4 weeks. The cells obtained from tumor mass when cultivated in vitro had a morphology comparable to those of the initial culture. 4. This cell line may prove useful for cellular and molecular studies as well as in studies of gliomas treatment.


Subject(s)
Glioma/pathology , Tumor Cells, Cultured/pathology , Aged , Animals , Astrocytoma/pathology , Brain Neoplasms/pathology , Carcinogenicity Tests/methods , Cell Culture Techniques/methods , Cell Division , Glioblastoma/pathology , Humans , Kinetics , Male , Mice , Mice, Nude , Neoplasm Transplantation/methods
17.
Medicina (B.Aires) ; 60(6): 931-939, Dic. 2000.
Article in Spanish | BINACIS | ID: bin-7411

ABSTRACT

We have established and characterized a cell line (LBL) from a spontaneous murine T lymphoma LB. Histopathological analysis has demonstrated LB primary tumor infiltration in spleen, lymph nodes, liver, thymus, bone marrow and lung. However LBL cells infiltrated all these organs except lung. Two sublines with different growth behavior were derived from LBL cell line. One of them grew in suspension as clusters (LBLc) while the other one grew as adherent monolayers (LBLa). Growth rate, response to mitogenic stimuli and apoptosis induction were different among the parental cell line and the derived sublines. CD44 was expressed constitutively in LBL and LBLa cells. In contrast LBLc cells only expressed similar levels of this molecule when stimulated with PMA. LBLa cells showed hyaluronic acid (HA) binding properties, while LBL and LBLc cells were not able to bind HA even when activated with PMA. We postulate that differences in HA binding could be related with different infiltration behaviors.(Au)


Subject(s)
Animals , Mice , Adjuvants, Immunologic/metabolism , Hyaluronan Receptors/metabolism , Hyaluronic Acid/metabolism , Leukemia, T-Cell/pathology , Tumor Cells, Cultured/pathology , Cell Division , Confidence Intervals , Flow Cytometry , Leukemia, T-Cell/metabolism , Mice, Inbred BALB C , Neoplasm Invasiveness , Protein Binding , Tumor Cells, Cultured/metabolism
18.
Oncol Rep ; 7(6): 1363-6, 2000.
Article in English | MEDLINE | ID: mdl-11032945

ABSTRACT

We show here, for the first time, in two very different murine tumors, a mammary one (ectoderm) and a lung one (endoderm), that: tumors have day/night differences of spontaneous apoptosis additional to the well-known circadian rhythm of mitosis. The times of maximal and minimal mitosis and apoptosis changed for a tumor cell line when growing in different organs (as metastasis) or anatomical sites. Both tumor lines, have identical circadian curves when growing in a specific organ or anatomical site. The peaks of apoptosis match with the valleys of mitosis and vice versa.


Subject(s)
Adenocarcinoma/pathology , Apoptosis/physiology , Circadian Rhythm/physiology , Lung Neoplasms/pathology , Mammary Neoplasms, Experimental/pathology , Mitosis/physiology , Tumor Cells, Cultured/pathology , Animals , Cell Division/physiology , Female , Male , Mice , Mice, Inbred BALB C , Neoplasm Transplantation , Peritoneal Cavity/pathology , Spleen/pathology
20.
Medicina (B Aires) ; 60(6): 931-9, 2000.
Article in Spanish | MEDLINE | ID: mdl-11436704

ABSTRACT

We have established and characterized a cell line (LBL) from a spontaneous murine T lymphoma LB. Histopathological analysis has demonstrated LB primary tumor infiltration in spleen, lymph nodes, liver, thymus, bone marrow and lung. However LBL cells infiltrated all these organs except lung. Two sublines with different growth behavior were derived from LBL cell line. One of them grew in suspension as clusters (LBLc) while the other one grew as adherent monolayers (LBLa). Growth rate, response to mitogenic stimuli and apoptosis induction were different among the parental cell line and the derived sublines. CD44 was expressed constitutively in LBL and LBLa cells. In contrast LBLc cells only expressed similar levels of this molecule when stimulated with PMA. LBLa cells showed hyaluronic acid (HA) binding properties, while LBL and LBLc cells were not able to bind HA even when activated with PMA. We postulate that differences in HA binding could be related with different infiltration behaviors.


Subject(s)
Adjuvants, Immunologic/metabolism , Hyaluronan Receptors/metabolism , Hyaluronic Acid/metabolism , Leukemia, T-Cell/pathology , Tumor Cells, Cultured/pathology , Animals , Cell Division , Confidence Intervals , Flow Cytometry , Leukemia, T-Cell/metabolism , Mice , Mice, Inbred BALB C , Neoplasm Invasiveness , Protein Binding , Tumor Cells, Cultured/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL